top of page
Ecosystem
Beta Site
Search Results
2 items found for " Masaya Ono"
Posts (1)
- Ono Enters into Collaboration Agreement with Domain Therapeutics and Université de Montréal for ...
April 2022 Ono Enters into Collaboration Agreement with Domain Therapeutics and Université de Montréal for GPCR-Targeted Drug Discovery "Apr.19.2022 Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; “Ono”) today announced that it has newly signed a collaboration
Other Pages (1)
- Blockade of vasoactive intestinal peptide receptor 2 (VIPR2) signaling suppresses cyclin D1-dependent cell-cycle progression in MCF-7 cells
Authors Satoshi Asano , Ami Ono , Kaede Baba , Teru Uehara , Kotaro Sakamoto , Atsuko Hayata-Takano ,
bottom of page